Jacobs Levy Equity Management, Inc Voyager Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $1.08 Million - $2.44 Million	-438,767 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $44,436 - $69,611	-16,896 Reduced 3.71%	438,767 $1.15 Million
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $417,663 - $576,672	-106,006 Reduced 18.87%	455,663 $1.88 Million
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $2.09 Million - $4.09 Million	452,885 Added 416.32%	561,669 $2.65 Million
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $180,458 - $309,934	25,239 Added 30.21%	108,784 $778,000
Q3 2020 Nov 16, 2020	BUY	$10.01 - $13.75 $204,394 - $280,761	20,419 Added 32.35%	83,545 $891,000
Q2 2020 Aug 17, 2020	BUY	$8.05 - $14.21 $388,211 - $685,277	48,225 Added 323.64%	63,126 $797,000
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $16,258 - $35,052	2,391 Added 19.11%	14,901 $136,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $450,238 - $591,772	-35,120 Reduced 73.74%	12,510 $175,000
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $288,523 - $500,450	17,690 Added 59.08%	47,630 $820,000
Q2 2019 Aug 13, 2019	SELL	$19.18 - $27.88 $540,971 - $786,355	-28,205 Reduced 48.51%	29,940 $815,000
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $465,160 - $1.14 Million	58,145 New	58,145 $1.11 Million
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $227,563 - $289,142	-13,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $222,908 - $318,136	13,300 New	13,300 $260,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.